TUTOR: A MULTICENTER, PHASE 1 TRIAL OF TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER

被引:0
|
作者
Ahluwalia, M. S. [1 ,2 ]
Ozair, A. [1 ,3 ]
Bardhan, M. [1 ]
Bellur, S. S. [1 ]
Perche, D. C. [1 ]
Starosciak, A. K. [1 ]
Khosla, A. A. [1 ]
Leon-Ariza, D. S. [1 ]
Rubens, M. [1 ]
Odia, Y. [1 ]
Mehta, M. P. [1 ,2 ]
Kotecha, R. R. [1 ,2 ]
McDermott, M. W. [2 ,4 ]
Leon, A. C. S. [1 ]
Mahtani, R. [1 ]
Peereboom, D. M. [5 ]
机构
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL USA
[3] Univ Maryland Med, Dept Neurosurg, Baltimore, MD USA
[4] Baptist Hlth South Florida, Miami Neurosci Inst, Miami, FL USA
[5] Cleveland Clin, Cleveland, OH USA
关键词
D O I
10.1093/neuonc/noae144.148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P06.11.A
引用
收藏
页码:V47 / V47
页数:1
相关论文
共 50 条
  • [21] The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis
    Petrelli, Fausto
    Ghidini, Michele
    Lonati, Veronica
    Tomasello, Gianluca
    Borgonovo, Karen
    Ghilardi, Mara
    Cabiddu, Mary
    Barni, Sandro
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 141 - 148
  • [22] Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
    Rupert Bartsch
    Anna Sophie Berghoff
    Julia Furtner
    Maximilian Marhold
    Elisabeth Sophie Bergen
    Sophie Roider-Schur
    Angelika Martina Starzer
    Heidrun Forstner
    Beate Rottenmanner
    Karin Dieckmann
    Zsuzsanna Bago-Horvath
    Helmuth Haslacher
    Georg Widhalm
    Aysegül Ilhan-Mutlu
    Christoph Minichsdorfer
    Thorsten Fuereder
    Thomas Szekeres
    Leopold Oehler
    Birgit Gruenberger
    Christian F. Singer
    Ansgar Weltermann
    Rainer Puhr
    Matthias Preusser
    Nature Medicine, 2022, 28 : 1840 - 1847
  • [23] Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Furtner, Julia
    Marhold, Maximilian
    Bergen, Elisabeth Sophie
    Roider-Schur, Sophie
    Starzer, Angelika Martina
    Forstner, Heidrun
    Rottenmanner, Beate
    Dieckmann, Karin
    Bago-Horvath, Zsuzsanna
    Haslacher, Helmuth
    Widhalm, Georg
    Ilhan-Mutlu, Aysegul
    Minichsdorfer, Christoph
    Fuereder, Thorsten
    Szekeres, Thomas
    Oehler, Leopold
    Gruenberger, Birgit
    Singer, Christian F.
    Weltermann, Ansgar
    Puhr, Rainer
    Preusser, Matthias
    NATURE MEDICINE, 2022, 28 (09) : 1840 - +
  • [24] Tucatinib versus placebo added to trastuzumab and capecitabine for patients with previously treated HER2+metastatic breast cancer with brain metastases (HER2CLIMB).
    Lin, Nancy U.
    Murthy, Rashmi Krishna
    Anders, Carey K.
    Borges, Virginia F.
    Hurvitz, Sara A.
    Loi, Sherene
    Abramson, Vandana G.
    Bedard, Philippe L.
    Oliveira, Mafalda
    Zelnak, Amelia Bruce
    DiGiovanna, Michael
    Bachelot, Thomas
    Chien, Amy Jo
    O'Regan, Ruth
    Wardley, Andrew M.
    Mueller, Volkmar
    Carey, Lisa A.
    McGoldrick, Suzanne M.
    An, Grace
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Stereotactic Radiosurgery for Brain Metastases From Breast Cancer
    Katrina S. Firlik
    Douglas Kondziolka
    John C. Flickinger
    L. Dade Lunsford
    Annals of Surgical Oncology, 2000, 7 : 333 - 338
  • [26] Stereotactic radiosurgery for brain metastases from breast cancer
    Firlik, KS
    Kondziolka, D
    Flickinger, JC
    Lunsford, LD
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (05) : 333 - 338
  • [27] Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial
    Okines, Alicia F. C.
    Curigliano, Giuseppe
    Mizuno, Nobumasa
    Oh, Do-Youn
    Rorive, Andree
    Soliman, Hatem
    Takahashi, Shunji
    Bekaii-Saab, Tanios
    Burkard, Mark E.
    Chung, Ki Y.
    Debruyne, Philip R.
    Fox, Jenny R.
    Gambardella, Valentina
    Gil-Martin, Marta
    Hamilton, Erika P.
    Monk, Bradley J.
    Nakamura, Yoshiaki
    Nguyen, Danny
    O'Malley, David M.
    Olawaiye, Alexander B.
    Pothuri, Bhavana
    Reck, Martin
    Sudo, Kazuki
    Sunakawa, Yu
    Van Marcke, Cedric
    Yu, Evan Y.
    Ramos, Jorge
    Tan, Sherry
    Bieda, Mark
    Stinchcombe, Thomas E.
    Pohlmann, Paula R.
    NATURE MEDICINE, 2025, : 909 - 916
  • [28] Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer (vol 12, pg 289, 2019)
    Murthy, Rashmi K.
    Loi, Sherene
    Okines, Alicia
    Paplomata, Elisavet
    Hamilton, Erika
    Hurvitz, Sara A.
    Lin, Nancy U.
    Borges, Virginia
    Abramson, Vandana
    Anders, Carey
    Bedard, Philippe L.
    Oliveira, Mafalda
    Jakobsen, Erik
    Bachelot, Thomas
    Shachar, Shlomit S.
    Mueller, Volkmar
    Braga, Sofia
    Duhoux, Francois P.
    Greil, Richard
    Cameron, David
    Carey, Lisa A.
    Curigliano, Giuseppe
    Gelmon, Karen
    Hortobagyi, Gabriel
    Krop, Ian
    Loibl, Sibylle
    Pegram, Mark
    Slamon, Dennis
    Palanca-Wessels, M. Corinna
    Walker, Luke
    Feng, Wentao
    Winer, Eric P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (06): : 586 - 586
  • [29] Multi-Institutional Report of Trastuzumab-Deruxtecan and Stereotactic Radiosurgery for HER2+Breast Cancer Brain Metastases
    Khatri, V.
    Mestres-Villanueva, M.
    Doniparthi, A.
    Smith, D. B.
    Nakashima, J. Y.
    Zhao, D.
    Bryant, J. M.
    Mills, M. N.
    Oliver, D. E.
    Yu, H. H. M.
    Han, H. S.
    Soliman, H.
    Perlow, H. K.
    Upadhyay, R.
    Palmer, J. D.
    Beyer, S.
    Ahmedm, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E243 - E244
  • [30] The role of stereotactic radiosurgery in the treatment of brain Metastases from her-2-neu breast cancer
    MacAusland, S. G.
    Noren, G.
    Wazer, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S182 - S182